MET receptor in oncology: From biomarker to therapeutic target.
Sign Up to like & getrecommendations! Published in 2020 at "Advances in cancer research"
DOI: 10.1016/bs.acr.2020.04.006
Abstract: First discovered in the 1984, the MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor or HGF (also known as scatter factor or SF) are implicated as key players in tumor cell migration,… read more here.
Keywords: receptor oncology; receptor; met receptor; oncology ... See more keywords